178 related articles for article (PubMed ID: 8896415)
21. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus-associated gastric adenocarcinomas among Koreans.
Shin WS; Kang MW; Kang JH; Choi MK; Ahn BM; Kim JK; Sun HS; Min KW
Am J Clin Pathol; 1996 Feb; 105(2):174-81. PubMed ID: 8607441
[TBL] [Abstract][Full Text] [Related]
23. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.
Cheung ST; Leung SF; Lo KW; Chiu KW; Tam JS; Fok TF; Johnson PJ; Lee JC; Huang DP
Int J Cancer; 1998 May; 76(3):399-406. PubMed ID: 9579578
[TBL] [Abstract][Full Text] [Related]
24. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
Guiretti DM; Chabay PA; Valva P; Stefanoff CG; Barros MH; De Matteo E; Renault IZ; Preciado MV; Hassan R
J Med Virol; 2007 Nov; 79(11):1730-22. PubMed ID: 17854036
[TBL] [Abstract][Full Text] [Related]
25. Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and malignant lympho-proliferations.
Berger C; Rothenberger S; Bachmann E; McQuain C; Nadal D; Knecht H
Int J Cancer; 1999 May; 81(3):371-5. PubMed ID: 10209951
[TBL] [Abstract][Full Text] [Related]
26. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
Robertson KD; Manns A; Swinnen LJ; Zong JC; Gulley ML; Ambinder RF
Blood; 1996 Oct; 88(8):3129-36. PubMed ID: 8874213
[TBL] [Abstract][Full Text] [Related]
27. Isolation and analysis of two strongly transforming isoforms of the Epstein-Barr-Virus(EBV)-encoded latent membrane protein-1 (LMP1) from a single Hodgkin's lymphoma.
Mehl AM; Fischer N; Rowe M; Hartmann F; Daus H; Trümper L; Pfreundschuh M; Müller-Lantzsch N; Grässer FA
Int J Cancer; 1998 Apr; 76(2):194-200. PubMed ID: 9537580
[TBL] [Abstract][Full Text] [Related]
28. Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil.
Araujo I; Foss HD; Bittencourt A; Hummel M; Demel G; Mendonca N; Herbst H; Stein H
Blood; 1996 Jun; 87(12):5279-86. PubMed ID: 8652843
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
Scheinfeld AG; Nador RG; Cesarman E; Chadburn A; Knowles DM
Am J Pathol; 1997 Sep; 151(3):805-12. PubMed ID: 9284829
[TBL] [Abstract][Full Text] [Related]
30. Deletions within the epstein-barr virus latent membrane protein-1 oncogene in adult ordinary, HIV-associated and paediatric Hodgkin's disease.
Santón A; Bellas C
Leuk Lymphoma; 2001 Jan; 40(3-4):235-42. PubMed ID: 11426545
[TBL] [Abstract][Full Text] [Related]
31. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
[TBL] [Abstract][Full Text] [Related]
32. Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms.
Lorenzetti MA; Gantuz M; Altcheh J; De Matteo E; Chabay PA; Preciado MV
J Clin Microbiol; 2012 Mar; 50(3):609-18. PubMed ID: 22205789
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
Longnecker R
Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus (EBV)-related oral squamous cell carcinoma in Okinawa, a subtropical island, in southern Japan--simultaneously infected with human papillomavirus (HPV).
Higa M; Kinjo T; Kamiyama K; Chinen K; Iwamasa T; Arasaki A; Sunakawa H
Oral Oncol; 2003 Jun; 39(4):405-14. PubMed ID: 12676263
[TBL] [Abstract][Full Text] [Related]
35. Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates.
Sandvej K; Gratama JW; Munch M; Zhou XG; Bolhuis RL; Andresen BS; Gregersen N; Hamilton-Dutoit S
Blood; 1997 Jul; 90(1):323-30. PubMed ID: 9207468
[TBL] [Abstract][Full Text] [Related]
36. Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review.
Anagnostopoulos I; Hummel M; Stein H
Leuk Lymphoma; 1995 Sep; 19(1-2):1-12. PubMed ID: 8574154
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus as an agent of haematological disease.
Tosato G; Taga K; Angiolillo AL; Sgadari C
Baillieres Clin Haematol; 1995 Mar; 8(1):165-99. PubMed ID: 7663046
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese.
Leung SY; Yuen ST; Chung LP; Chan AS; Wong MP
Int J Cancer; 1997 Jul; 72(2):225-30. PubMed ID: 9219824
[TBL] [Abstract][Full Text] [Related]
39. Association of a distinctive strain of Epstein-Barr virus with gastric cancer.
Corvalan A; Ding S; Koriyama C; Carrascal E; Carrasquilla G; Backhouse C; Urzua L; Argandoña J; Palma M; Eizuru Y; Akiba S
Int J Cancer; 2006 Apr; 118(7):1736-42. PubMed ID: 16217758
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
